Drawing for SMART NANOMACHINE

USPTO serial 88258302

SMART NANOMACHINE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
FOSTER, ALEXANDRA M.
Law office
LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SMART NANOMACHINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, a drug delivery system comprising polymer micelle nanocarriers for targeted drug and gene delivery; pharmaceutical preparations, namely, an anticancer drug coated with polymer micelle; contrast media for use with MRI equipment; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules, tablets or powders that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral drug tablets, transdermal creams, compresses and patches for delivery of pharmaceuticals and injectable pharmaceuticals, all for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for cancer, brain tumor, Alzheimer, dementia, Parkinson's disease, hepatitis C, osteoarthritis, influenza, arteriosclerosis, spinal muscular atrophy, cerebral infarct, cerebral aneurysm, headache, epilepsy, ALS, myocardial infarction, angina, rheumatism, connective tissue disease, gout, measles, rubella, mumps, chickenpox, herpes zoster, tuberculosis, herpes, norovirus infection, hay fever and asthma; reagent paper for medical purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jun 3, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 2, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 30, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 4, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2019DOCKASSIGNED TO EXAMINER
Feb 1, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 1, 2019AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jan 31, 2019ALIEASSIGNED TO LIE
Jan 20, 2019ALIEASSIGNED TO LIE
Jan 17, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED
Jan 15, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance